Advanced Processes for Quality Control to Improve Commercialization for Cell and Gene Therapies

The science of cell therapy is advancing quickly, but manufacturing for these lifesaving treatments hasn't kept pace. This creates challenges in commercialization speed and cost as well as significant hurdles to quality management.

Ascential's new eBook outlines Quality-by-Design (QbD) principles for Cell and Gene therapy that can guide the complex development of manufacturing processes to ensure high-quality, repeatable results.

In this eBook, you'll learn how key processes in quality management can improve the commercialization pathway, in particular:

• Quality control challenges in cell therapy manufacturing systems
• Four key steps to delivering an end-to-end QbD process
• Enabling technologies driving innovation in quality management